1. Home
  2. NTRA vs SHG Comparison

NTRA vs SHG Comparison

Compare NTRA & SHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$244.06

Market Cap

27.0B

Sector

Health Care

ML Signal

HOLD

Logo Shinhan Financial Group Co Ltd

SHG

Shinhan Financial Group Co Ltd

HOLD

Current Price

$54.28

Market Cap

26.4B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
SHG
Founded
2003
1982
Country
United States
South Korea
Employees
N/A
N/A
Industry
Medical Specialities
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
27.0B
26.4B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
NTRA
SHG
Price
$244.06
$54.28
Analyst Decision
Strong Buy
Analyst Count
16
0
Target Price
$227.69
N/A
AVG Volume (30 Days)
1.7M
185.4K
Earning Date
11-06-2025
10-30-2025
Dividend Yield
N/A
2.27%
EPS Growth
N/A
9.37
EPS
N/A
6.76
Revenue
$2,116,676,000.00
$10,722,437,949.00
Revenue This Year
$32.77
$6.52
Revenue Next Year
$16.51
$3.97
P/E Ratio
N/A
$7.89
Revenue Growth
38.17
0.61
52 Week Low
$125.38
$28.76
52 Week High
$245.59
$56.13

Technical Indicators

Market Signals
Indicator
NTRA
SHG
Relative Strength Index (RSI) 80.03 53.03
Support Level $233.67 $53.61
Resistance Level $240.18 $56.13
Average True Range (ATR) 7.39 0.89
MACD 0.68 -0.02
Stochastic Oscillator 97.49 56.32

Price Performance

Historical Comparison
NTRA
SHG

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About SHG Shinhan Financial Group Co Ltd

Shinhan Financial Group Co Ltd is a Korean banking group. Along with its subsidiaries the company provides, comprehensive financial services which consist of commercial banking services, credit card services, securities services, insurance, credit services, and asset management services, including securities investment trust management, investment advisory, call transaction, domestic and foreign private equity fund business, and other services. The majority of the revenue is generated from its Banking business which includes retail, corporate, international, and other banking services the company offers.

Share on Social Networks: